SCICLONE PHARMACEUTICALS INC Long-Lived Assets
SCICLONE PHARMACEUTICALS INC had Long-Lived Assets of $46.60 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2017-08-09
- 2017-06-30: Long-Lived Assets $46.60M.
- 2017-03-31: Long-Lived Assets $46.34M.
- 2016-12-31: Long-Lived Assets $46.16M.
- 2016-09-30: Long-Lived Assets $49.13M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2017-06-30 | $46.60M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.34M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $46.16M 10-Q · filed 2017-08-09 | |
| 2016-09-30 | $49.13M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $46.82M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $48.12M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $48.10M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $48.41M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $49.48M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $42.29M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $41.63M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $39.50M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $36.11M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $35.73M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $36.44M 10-K · filed 2014-03-17 | |
| 2013-09-30 | $36.45M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $36.26M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $36.32M 10-Q · filed 2013-08-09 | |
| 2012-09-30 | $36.12M 10-Q/A · filed 2013-04-01 | $34.22M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $78.97M 10-Q/A · filed 2013-04-01 | $77.07M 10-Q · filed 2012-08-08 |